157 related articles for article (PubMed ID: 7828138)
1. Neuroendocrine differentiation of adrenocortical tumors.
Haak HR; Fleuren GJ
Cancer; 1995 Feb; 75(3):860-4. PubMed ID: 7828138
[TBL] [Abstract][Full Text] [Related]
2. Expression of intermediate filament proteins in adrenal cortex and related tumours.
Henzen-Logmans SC; Stel HV; van Muijen GN; Mullink H; Meijer CJ
Histopathology; 1988 Apr; 12(4):359-72. PubMed ID: 2453435
[TBL] [Abstract][Full Text] [Related]
3. [Adrenocortical tumors with neuroendocrine differentiation].
Kazantseva IA; Poliakova GA; Gurevich LG; Morozov IA; Bezuglova TV; Smirnov VB
Arkh Patol; 2002; 64(5):8-13. PubMed ID: 12575533
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine differentiation in adrenocortical carcinoma. New immunohistochemical findings supported by electron microscopy.
Miettinen M
Lab Invest; 1992 Feb; 66(2):169-74. PubMed ID: 1735954
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine differentiation and nerves in human adrenal cortex and cortical lesions.
Li Q; Johansson H; Kjellman M; Grimelius L
APMIS; 1998 Aug; 106(8):807-17. PubMed ID: 9744767
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S
Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
[TBL] [Abstract][Full Text] [Related]
7. Adrenal cortical tumors clinically mimicking pheochromocytoma.
Alsabeh R; Mazoujian G; Goates J; Medeiros LJ; Weiss LM
Am J Clin Pathol; 1995 Oct; 104(4):382-90. PubMed ID: 7572786
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine properties of adrenocortical cells.
Ehrhart-Bornstein M; Hilbers U
Horm Metab Res; 1998; 30(6-7):436-9. PubMed ID: 9694576
[TBL] [Abstract][Full Text] [Related]
9. Expression of inhibin alpha in the human adrenal gland and adrenocortical tumors.
Arola J; Liu J; Heikkilä P; Voutilainen R; Kahri A
Endocr Res; 1998; 24(3-4):865-7. PubMed ID: 9888589
[TBL] [Abstract][Full Text] [Related]
10. Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: neuroendocrine properties of tumors associated with Carney complex.
Stratakis CA; Carney JA; Kirschner LS; Willenberg HS; Brauer S; Ehrhart-Bornstein M; Bornstein SR
J Clin Endocrinol Metab; 1999 Mar; 84(3):1122-8. PubMed ID: 10084605
[TBL] [Abstract][Full Text] [Related]
11. Chicken ovalbumin upstream promoter transcription factor II in the human adrenal cortex and its disorders.
Suzuki T; Takahashi K; Darnel AD; MoriyaT ; Murakami O; Narasaka T; Takeyama J; Sasano H
J Clin Endocrinol Metab; 2000 Aug; 85(8):2752-7. PubMed ID: 10946877
[TBL] [Abstract][Full Text] [Related]
12. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic value of A103 and inhibin-alpha in adrenocortical tumors: an immunohistochemical study using tissue microarray techniques].
Zhang HY; Wang XJ; Liu WP; Jiang LL; Li GD; Guo J; Zhang YH
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):203-7. PubMed ID: 15256108
[TBL] [Abstract][Full Text] [Related]
14. Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas.
Peri A; Luciani P; Conforti B; Baglioni-Peri S; Cioppi F; Crescioli C; Ferruzzi P; Gelmini S; Arnaldi G; Nesi G; Serio M; Mantero F; Mannelli M
J Clin Endocrinol Metab; 2001 Nov; 86(11):5443-9. PubMed ID: 11701720
[TBL] [Abstract][Full Text] [Related]
15. Histologic and immunohistochemical classification of 41 bovine adrenal gland neoplasms.
Grossi AB; Leifsson PS; Jensen HE; Vainer B; Iburg T
Vet Pathol; 2013 May; 50(3):534-42. PubMed ID: 23242804
[TBL] [Abstract][Full Text] [Related]
16. Nestin as a marker in the classification of adrenocortical tumors.
Lachenmayer A; Lichtenauer UD; Cox T; Schott M; Malendowicz LK; Goretzki PE; Cupisti K; Scherbaum WA; Bornstein SR; Willenberg HS
Horm Metab Res; 2009 May; 41(5):397-401. PubMed ID: 19294612
[TBL] [Abstract][Full Text] [Related]
17. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas.
Mannelli M; Gelmini S; Arnaldi G; Becherini L; Bemporad D; Crescioli C; Pazzagli M; Mantero F; Serio M; Orlando C
J Clin Endocrinol Metab; 2000 Jan; 85(1):468-70. PubMed ID: 10634426
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of epidermal growth factor receptors in human adrenocortical carcinoma.
Kamio T; Shigematsu K; Sou H; Kawai K; Tsuchiyama H
Hum Pathol; 1990 Mar; 21(3):277-82. PubMed ID: 2312105
[TBL] [Abstract][Full Text] [Related]
20. Nestin expression in normal adrenal gland and adrenocortical tumors.
Toti P; Regoli M; Nesi G; Occhini R; Bartolommei S; Fonzi L; Bertelli E
Histol Histopathol; 2005 Oct; 20(4):1115-20. PubMed ID: 16136494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
